Oaktree Acquisition Corp. III (OACC) is a dedicated acquisition company targeting transformative opportunities in the life sciences sector, particularly in healthcare technology, therapeutics, and medical devices. Backed by a seasoned management team with a strong track record in healthcare investments, OACC is committed to driving innovation and value creation through strategic mergers and partnerships. By employing rigorous due diligence and a proactive investment approach, the company is poised to capitalize on the evolving dynamics of the life sciences market, ultimately enhancing shareholder value in a rapidly changing landscape.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -0.38% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.29 |
| Price-to-Book | 1.35 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -16.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $19.78M |
| Float | $18.46M |
| % Insiders | 0.00% |
| % Institutions | 90.66% |
Volatility is currently expanding